Skip to main content
Premium Trial:

Request an Annual Quote

Neogen, Foxo Technologies Collaborate on Epigenetic Study of Human Health

NEW YORK − Food and animal safety firm Neogen and Foxo Technologies, a firm that plans to use epigenetic biomarkers for life insurance, said on Friday that they have been jointly investigating the association between epigenetic aging and environmental risk factors, as well as morbidity and mortality outcomes.

The collaboration taps decades worth of blood samples and data collected by the Physicians' Health Study, a large-scale trial initiated by Brigham and Women's Hospital in 1982, to conduct comprehensive epigenetic profiling. 

As part of the project, Neogen's genomics team processed more than 11,000 blood samples in its recently CLIA-certified laboratory, extracting DNA for analysis on Illumina Epic Methylation arrays, the company said. The data was then sent to Foxo for high-throughput bioinformatic processing and epigenetic analysis.

"This research project has been a very exciting undertaking for both Foxo and Neogen," Foxo CSO Brian Chen said in a statement. The project "allows us to dramatically expand the frontiers of epigenetics and human health."

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.